{"pmid":32366113,"title":"Foot Manifestations in a COVID-19 Positive Patient: A Case Study.","text":["Foot Manifestations in a COVID-19 Positive Patient: A Case Study.","J Am Podiatr Med Assoc","Nirenberg, Michael S","Del Mar Ruiz Herrera, Maria","32366113"],"journal":"J Am Podiatr Med Assoc","authors":["Nirenberg, Michael S","Del Mar Ruiz Herrera, Maria"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366113","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.7547/20-088","keywords":["covid foot","covid toes","covid-19","coronavirus"],"topics":["Case Report"],"weight":1,"_version_":1666138496246480896,"score":9.490897,"similar":[{"pmid":32329897,"title":"Chilblain-like lesions on feet and hands during the COVID-19 Pandemic.","text":["Chilblain-like lesions on feet and hands during the COVID-19 Pandemic.","Int J Dermatol","Landa, Nerea","Mendieta-Eckert, Marta","Fonda-Pascual, Pablo","Aguirre, Teresa","32329897"],"journal":"Int J Dermatol","authors":["Landa, Nerea","Mendieta-Eckert, Marta","Fonda-Pascual, Pablo","Aguirre, Teresa"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329897","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ijd.14937","topics":["Case Report"],"weight":1,"_version_":1666138494618042368,"score":45.840668},{"pmid":32504454,"title":"Manifestations in Neonates Born to COVID-19 Positive Mothers.","text":["Manifestations in Neonates Born to COVID-19 Positive Mothers.","Indian J Pediatr","Jain, Parul","Thakur, Anup","Kler, Neelam","Garg, Pankaj","32504454"],"journal":"Indian J Pediatr","authors":["Jain, Parul","Thakur, Anup","Kler, Neelam","Garg, Pankaj"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504454","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s12098-020-03369-x","topics":["Case Report"],"weight":1,"_version_":1668892488269561856,"score":43.419147},{"pmid":32410816,"pmcid":"PMC7221364","title":"A case series of chest imaging manifestation of COVID-19.","text":["A case series of chest imaging manifestation of COVID-19.","Coronavirus disease 2019 (COVID-19) is caused by a infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. It started in Wuhan, China, in December 2019, after which quickly spread to many other countries around the world. Chest radiography (CXR) and computed tomography (CT) play key roles in managment and diagnosis of COVID-19. In this case series we are presenting three patients with predominant left-sided changes caused by COVID-19 infection.","Radiography (Lond)","Vegar-Zubovic, Sandra","Izetbegovic, Sebija","Zukic, Fuad","Jusufbegovic, Merim","Kristic, Spomenka","Prevljak, Sabina","Sehic, Adnan","Julardzija, Fuad","32410816"],"abstract":["Coronavirus disease 2019 (COVID-19) is caused by a infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. It started in Wuhan, China, in December 2019, after which quickly spread to many other countries around the world. Chest radiography (CXR) and computed tomography (CT) play key roles in managment and diagnosis of COVID-19. In this case series we are presenting three patients with predominant left-sided changes caused by COVID-19 infection."],"journal":"Radiography (Lond)","authors":["Vegar-Zubovic, Sandra","Izetbegovic, Sebija","Zukic, Fuad","Jusufbegovic, Merim","Kristic, Spomenka","Prevljak, Sabina","Sehic, Adnan","Julardzija, Fuad"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32410816","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.radi.2020.05.003","keywords":["covid-19","computed tomography (ct)","coronavirus","chest radiography (cxr)"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666897318927925248,"score":41.330456},{"pmid":32414622,"title":"Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report.","text":["Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report.","The 2019 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was first reported in Wuhan, China last December 2019, has been declared an emergency by the World Health Organization but eventually progressed to become a Pandemic. To date, Coronavirus Disease 2019 (COVID-19) has affected at least 100,000 individuals worldwide, reaching thousands of mortalities (Zhou et al., 2020; World Health Organization, 2020). In the Philippines, the number of COVID-19 confirmed positive cases is over 636 and is expected to rise (Department of Health, 2020). Respiratory infections alongside their comorbidities can induce acute myocardial infarction and acute ischemic stroke (Warren-Gash et al., 2018) [3]. These may further bring challenges in the management and administration of Intravenous (IV) Alteplase in eligible patients. Currently, there are no case reports in the administration IV Altepase in ischemic stroke patients who are COVID-19 positive. We present a case of a 62-year old female who was admitted due to cough, colds and shortness of breath of 2 weeks duration and was tested to be COVD-19 positive. She suffered from an ischemic stroke while in the Medical Intensive Care Unit and was given Intravenous thrombolysis.","J Clin Neurosci","Co, Christian Oliver C","Yu, Jeryl Ritzi T","Laxamana, Lina C","David-Ona, Deborah Ignacia A","32414622"],"abstract":["The 2019 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was first reported in Wuhan, China last December 2019, has been declared an emergency by the World Health Organization but eventually progressed to become a Pandemic. To date, Coronavirus Disease 2019 (COVID-19) has affected at least 100,000 individuals worldwide, reaching thousands of mortalities (Zhou et al., 2020; World Health Organization, 2020). In the Philippines, the number of COVID-19 confirmed positive cases is over 636 and is expected to rise (Department of Health, 2020). Respiratory infections alongside their comorbidities can induce acute myocardial infarction and acute ischemic stroke (Warren-Gash et al., 2018) [3]. These may further bring challenges in the management and administration of Intravenous (IV) Alteplase in eligible patients. Currently, there are no case reports in the administration IV Altepase in ischemic stroke patients who are COVID-19 positive. We present a case of a 62-year old female who was admitted due to cough, colds and shortness of breath of 2 weeks duration and was tested to be COVD-19 positive. She suffered from an ischemic stroke while in the Medical Intensive Care Unit and was given Intravenous thrombolysis."],"journal":"J Clin Neurosci","authors":["Co, Christian Oliver C","Yu, Jeryl Ritzi T","Laxamana, Lina C","David-Ona, Deborah Ignacia A"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414622","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jocn.2020.05.006","keywords":["covid-19","coronavirus","iv-rtpa","sars-cov-2","stroke"],"locations":["Wuhan","China","Philippines"],"countries":["China","Philippines"],"countries_codes":["CHN|China","PHL|Philippines"],"topics":["Case Report"],"weight":1,"_version_":1666994545891475456,"score":40.0488}]}